U.S. Chemicals Stock News

Kyivstar, VEON's digital operator in Ukraine, recently completed the first field test of Starlink Direct to Cell technology in eastern Europe, followed by its business combination and debut on Nasdaq as the first pure-play Ukrainian investment in U.S. stock markets. This move increases VEON's visibility and investor access while highlighting ongoing innovation in digital connectivity and a renewed focus on larger, scalable markets after the sale of its Kyrgyzstan operations. We'll examine...

In August 2025, California Resources Corporation announced its second quarter results, highlighting a substantial year-over-year increase in revenue, net income, and production, alongside the completion of a major share buyback and declaration of a quarterly dividend. A key insight is the company's rapid turnaround, moving from a small net loss a year earlier to strong profitability, signaling significant operational and financial improvements. We'll explore how record quarterly production...

Cullen/Frost Bankers is currently offering a 3.2% dividend yield, surpassing both industry and S&P 500 averages, and has raised dividends five times over the last five years with an average annual increase of 7.98%. This consistent record of dividend growth, underpinned by projected earnings increases, has heightened Cullen/Frost's appeal among income-focused investors and signals stability in its financial outlook. With a strong and rising dividend yield in focus, we’ll explore how this...

Earlier this month, Corpay Inc. announced that its Cross-Border business can now facilitate client FX conversions using J.P. Morgan's Kinexys Digital Payments blockchain, enabling near real-time value transfer and settlement beyond traditional banking hours. This marks a meaningful advancement in the use of blockchain for cross-border payments, expanding operational flexibility and demonstrating the practical impact of JPMorgan Chase's technology investments. With this partnership...

Charles Schwab reported that at the end of July, client assets increased 15% year-over-year and 2% month-over-month, with core net new assets reaching US$46.9 billion, up 62% from the previous period. This surge in client assets and net inflows reflects continued growth in Schwab’s customer base and may indicate strengthening engagement across its financial services. We'll explore how the significant increase in net new assets may influence the company's long-term investment narrative and...

Alliance Resource Partners, L.P. recently promoted Jesse M. Parrish to Senior Vice President and Chief Commercial Officer of its subsidiary, Alliance Coal, LLC, entrusting him with leadership over sales, marketing, logistics, and government relations. This leadership move signals a broadening of focus toward commercial strategy in power infrastructure and efforts to support the longevity of the national coal fleet. We’ll examine how Mr. Parrish’s expanded responsibility for commercial...

Danaher recently announced second-quarter 2025 earnings, reporting an EPS of US$1.80 that surpassed analyst expectations of US$1.64 and drawing positive attention from institutional investors like Parnassus Investments. Commentary from investors highlights Danaher's significant scale advantages and strongly embedded role in biopharma workflows, supporting its positioning in areas such as biologics, genetic medicine, and diagnostics. With Danaher's latest results exceeding forecasts, we'll...

Loar Holdings Inc. reported its second quarter 2025 results on August 13, 2025, posting sales of US$123.12 million and net income of US$16.71 million, both higher than the prior-year period. The company's basic earnings per share from continuing operations doubled year-over-year, highlighting a period of accelerating profitability. We’ll explore how this strong earnings growth sharpens Loar Holdings’ investment narrative and future growth outlook. Rare earth metals are the new gold rush...

Pharvaris announced its second quarter and half-year 2025 earnings, reporting a net loss of €45.48 million and €91.82 million, respectively, both increasing from the prior year. This results update highlights rising operating expenses or investment activity, reflected in an increasing loss per share for both periods compared to last year. To understand how higher reported losses impact expectations for Pharvaris, we’ll explore what this means for the company’s investment narrative. Uncover...

On August 4, 2025, ChoiceOne Bank announced the transition of its investment program to the Ameriprise Financial Institution Group, now operating as ChoiceOne Wealth Management with approximately US$780 million in assets managed across Michigan by 10 financial advisors and two support staff. This move broadens Ameriprise Financial’s institutional footprint and gives ChoiceOne clients access to expanded advisory services, investment products, and digital client engagement tools. We'll look at...

Live Nation Entertainment recently reported second quarter and first half 2025 results, highlighting increased revenues to US$7.01 billion and US$10.39 billion, respectively, but a lower quarterly net income year-on-year. Even as net income declined for the recent quarter compared to last year, cumulative earnings for the first half of 2025 showed improvement, suggesting shifts in profit timing and possibly higher costs impacting quarterly margins. We'll explore how Live Nation's robust...

Earlier this month, Broadcom Inc. began shipping the Jericho4 ethernet fabric router, a platform built to interconnect over one million XPUs across distributed AI data centers, marking a step-change in scalable networking for high-performance computing. This development highlights Broadcom’s comprehensive approach to AI infrastructure, leveraging both leading-edge hardware innovation and integration of its broad networking portfolio to serve accelerating demands from AI and hyperscale...

Earlier this week, Enterprise Products Partners responded to a crude oil leak at its southeast Houston terminal, which was quickly contained with no reported injuries or offsite impact, as cleanup and collaboration with regulators began immediately. An important insight is that this operational incident unfolded while the company was in the midst of advancing US$6 billion in ongoing growth projects, highlighting the balance between operational risks and a substantial expansion plan. We’ll...

Aveanna Healthcare Holdings Inc. recently reported strong second-quarter results, with sales increasing to US$589.55 million and net income reaching US$27.03 million, while also updating its full-year 2025 revenue guidance to above US$2.3 billion and disclosing an impairment loss of US$153,000 for the quarter. Despite recording a higher impairment loss compared to the previous year, the company’s improved earnings and raised revenue outlook suggest operational momentum as demand for its home...

In August 2025, Intercontinental Exchange announced an expanded global climate data and analytics service, now offering climate risk metrics and greenhouse gas emissions data for over five million private companies, and Chainlink revealed that ICE's FX and precious metals rates will power its blockchain data streams for over 2,000 applications. This marks a significant step in applying advanced risk analytics and trusted real-world market data to both traditional and decentralized finance,...

BigBear.ai recently announced the successful integration of its Pangiam Threat Detection platform with Smiths Detection's HI-SCAN 6040 CTiX systems, bringing real-time automated security screening to airports worldwide and marking a key step towards modernizing aviation and border security. This rollout, combined with new airport trials, highlights BigBear.ai’s ability to rapidly deploy advanced AI technologies in critical security environments following a period of substantial financial...

Guardant Health recently reported second quarter results showing strong demand across its core oncology and screening businesses, with management raising full-year revenue guidance on the back of rapid product adoption and expanding biopharma partnerships. An interesting insight is that despite ongoing operating losses and continued reinvestment, the revised outlook reflected management's confidence in sustained growth, coinciding with positive sector sentiment following speculation of lower...

AbbVie has announced a US$195 million investment to expand its North Chicago, Illinois manufacturing plant, enhancing domestic active pharmaceutical ingredient production to support neuroscience, immunology, and oncology medicines, with construction starting in fall 2025 and full operations expected by 2027. This expansion is part of AbbVie’s broader commitment to invest over US$10 billion in the U.S., strengthening its footprint in domestic manufacturing and job creation while reinforcing...

MPLX LP recently announced second-quarter 2025 earnings, reporting stable revenue year-over-year at US$3.00 billion and net income of US$1.05 billion, alongside a Board-approved plan authorizing up to US$1 billion in new share repurchases with no expiration date. The new, sizable buyback authorization came as the company wrapped up a previous repurchase effort, aligning with ongoing disciplined capital returns and potentially signaling further management confidence in MPLX's outlook. We will...

Earlier this month, Paymentus Holdings announced strong second quarter results with revenue reaching US$280.08 million and net income rising to US$14.71 million, accompanied by new earnings guidance for the third quarter and full year 2025. The company's management also presented at the Oppenheimer 28th Annual Technology, Internet & Communications Conference, underlining its engagement with the investment community soon after its financial updates. We'll explore how Paymentus Holdings'...

Scholar Rock announced that pivotal Phase 3 SAPPHIRE trial results for its investigational SMA treatment apitegromab were published in The Lancet Neurology, showing improved motor function in children and adults with SMA compared to placebo, with all patients continuing on standard SMN-targeted care. This marks apitegromab as the first muscle-targeted therapy candidate in SMA to show clinical success in a pivotal phase 3 trial, and the treatment is currently under FDA priority review with a...

NasdaqGS:FELE 1 Year Share Price vs Fair Value Explore Franklin Electric's Fair Values from the Community and select...

H.B. Fuller Company's ( NYSE:FUL ) price-to-earnings (or "P/E") ratio of 31.7x might make it look like a strong sell...

NasdaqGS:CRWD 1 Year Share Price vs Fair Value Explore CrowdStrike Holdings's Fair Values from the Community and select...